Multiple metabolic enzymes requiring B-vitamin cofactors

Multiple metabolic enzymes requiring B-vitamin cofactors refers to a broad functional class of proteins that utilize B-vitamin derivatives as essential coenzymes or prosthetic groups to facilitate biochemical transformations (Kennedy, 2016, Nutrients). This group includes critical enzymes such as pyruvate dehydrogenase (requiring thiamine pyrophosphate/B1), various dehydrogenases in the TCA cycle (requiring NAD+/B3 and FAD/B2), and aminotransferases (requiring pyridoxal phosphate/B6) (NIH Office of Dietary Supplements). These enzymes are central to cellular energy production, DNA synthesis, and the maintenance of the nervous system (Stipanuk & Caudill, 2018, Biochemical, Physiological, and Molecular Aspects of Human Nutrition). While not a single therapeutic target, this collective is clinically significant; deficiencies lead to metabolic disorders like beriberi or megaloblastic anemia, while specific enzymes within this group are targeted by drugs like methotrexate, which inhibits dihydrofolate reductase (B9-dependent) to treat cancer and autoimmune diseases (PubChem, CID 126941; StatPearls, 2023). Because the term encompasses hundreds of distinct enzymes across various pathways, it is classified as a descriptive category rather than a specific molecular target (UniProt).

Other names

B-vitamin dependent enzymesCofactor-dependent metabolic enzymesVitamin B-dependent pathways

B-vitamins act as precursors to essential cofactors (e.g., TPP, NAD, FAD, PLP, CoA, THF) that bind to apoenzymes to form functional holoenzymes, thereby enabling metabolic catalysis (Kennedy, 2016, Nutrients). Conversely, antimetabolite drugs competitively inhibit these enzymes by mimicking the substrate or the cofactor, effectively blocking metabolic pathways such as DNA synthesis (PubChem).